Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Taysha Gene Therapies Inc
(NQ:
TSHA
)
2.200
-0.040 (-1.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Taysha Gene Therapies Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
August 15, 2023
Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with...
Via
Benzinga
Exposures
Product Safety
What 6 Analyst Ratings Have To Say About Taysha Gene Therapies
August 15, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 15, 2023
Pre-market stock movers are a hot topic with investors this morning and we're checking out the biggest ones worth watching on Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
August 14, 2023
Via
Benzinga
Why Taysha Gene Therapies Stock Is Surging
August 14, 2023
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares are surging higher Monday.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Taysha Gene Therapies
June 30, 2023
Via
Benzinga
Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
August 14, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
August 14, 2023
Via
Benzinga
US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet
August 14, 2023
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The Dow traded up 0.01% to 35,284.34 while the NASDAQ rose 0.64% to 13,732.05....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Falls 50 Points; Monday.com Posts Upbeat Results
August 14, 2023
U.S. stocks traded mostly lower this morning, with the Dow Jones falling around 50 points on Monday. Following the market opening Monday, The Dow traded down 0.14% to 35,230.38 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Ratings for Taysha Gene Therapies
May 12, 2023
Via
Benzinga
Recap: Taysha Gene Therapies Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Preview: Taysha Gene Therapies
May 10, 2023
Via
Benzinga
12 Analysts Have This to Say About Taysha Gene Therapies
March 29, 2023
Via
Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 14, 2023
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 14, 2023
Via
Benzinga
Taysha Gene Therapies's Earnings: A Preview
March 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 15, 2023
On Wednesday, 479 stocks made new 52-week lows.
Via
Benzinga
Taysha Gene Therapies Touts Encouraging Preclinical Data From Rett Syndrome Candidate
May 19, 2023
Taysha Gene Therapies Inc (NASDAQ: TSHA) presented preclinical data from neonatal mouse models on TSHA-102 for Rett syndrome, including new data in wild-type mice, at the American Society of Gene and...
Via
Benzinga
FDA's Approval For Sarepta's Duchenne Gene Therapy, A Boost for Taysha Gene's Rare Neuropathy Treatment: Analyst Weighs
May 15, 2023
On Friday, the FDA's adcomm voted 8 to 6 in support of accelerated approval of Sarepta Therapeutics Inc's SRPT SRP-9001 (delandistrogene moxeparvovec) for ambulatory patients with
Via
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 29, 2023
On Wednesday, 81 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 16, 2023
Thursday's session saw 337 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 24, 2023
On Friday, 135 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 24, 2023
On Friday, 469 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 15, 2023
On Wednesday, 35 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
February 10, 2023
During Friday, 48 stocks hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
February 02, 2023
Via
Benzinga
US Stocks Turn Higher After Fed Raises Key Overnight Interest Rate; Nasdaq Up 1.5%
February 01, 2023
U.S. stocks turned higher toward the end of trading, following the release of interest rate decision. The Dow traded up 0.05% to 34,104.56 while the NASDAQ rose 1.58% to 11,767.44. The S&P 500 also...
Via
Benzinga
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 01, 2023
Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.